Roic AI
Search
/
Search
/
Pricing
Sign inSign up

You're using the beta version. You're using the beta version of the new website.

SummaryFinancialsRatiosTranscriptsClassic View

Footer

Found an error or have an idea?
or write us an email to [email protected]

Company

  • About
  • Pricing
  • Blog

Support

  • Knowledge Base
  • FAQ

Legal

  • Privacy Policy

© 2023 Roic AI, Inc. All rights reserved.

  1. United States Stocks
  2. •

    Healthcare
  3. •

    Medical Care Facilities

93.72

USD
-1.38
(-1.45%)

Company News

  • Investor's Business Daily

    5 months ago

    DaVita Stock Sees Rising Relative Strength

  • MarketWatch.com

    5 months ago

    Novavax and Palantir rocket higher, while PayPal slumps and other stocks on the move

  • Barrons Online

    5 months ago

    DaVita Is the S&P 500’s Top Gainer. Here’s Why the Dialysis Stock Is Surging.

  • Barron's

    5 months ago

    DaVita Is the S&P 500's Top Gainer. Why the Dialysis Stock Is Surging.

  • Barrons Online

    5 months ago

    Stock Market News

  • Dow Jones Newswires

    5 months ago

    DaVita 1Q Rev $2.87B >DVA

  • The Wall Street Journal

    6 months ago

    Aerospace Executives Go to Trial Over Alleged No-Poach Deals

  • The Wall Street Journal

    10 months ago

    Junk Bonds Rally on Hopes Inflation Has Peaked

  • MarketWatch.com

    10 months ago

    Unprofitable public companies gambled more than $200 million in California, and lost big

  • MarketWatch.com

    a year ago

    Dialysis company DaVita stock suffered worst day in 22 years after big profit miss, disappointing outlook

  • Barron's

    a year ago

    DaVita Stock Plummets Most Since 2000 on Outlook Cut

  • MarketWatch.com

    a year ago

    DaVita stock falls as higher wages, missed treatments push earnings below Street expectations

  • The Wall Street Journal

    a year ago

    First Criminal Wage-Fixing Trials End in Loss for DOJ

  • The Wall Street Journal

    2 years ago

    Not Sure How Much You Should Be Paid? Colorado Could Offer Some Clues

  • Barron's

    2 years ago

    Active Funds Are Doing Better. This Is What's Helping Them.

  • MarketWatch.com

    2 years ago

    DaVita and its former CEO indicted, Justice Department charges illegal 'no poaching' deals with rivals

DaVita Inc. logo

DaVita Inc.

DVA US

DVA USDaVita Inc.USUS
FIGI: BBG000MQ1SN9

Company Description

CEO
Mr. Javier J. Rodriguez
Full Time Employees
70,000
Sector
Healthcare
Industry
Medical Care Facilities
Address
2000 16th Street Denver CO United States 80202
CIK
0000927066
Website
www.davita.com
Business
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
5.04EPS Dil.
18.17P/E
8.55BMarket Cap
Next Earnings
October 26
Held by Insiders
3.23%
Held by Institutions
90.03%
Short % of Float
2.71%
YTD Yield
6.41%
3Y Yield
12.82%
Growth Rates
USD

•

in mil. unless spec.
(avg. rate of change)
10 years
5 years
1 year
Sales/Revenue/Turnover
4.76%
1.33%
-0.08%
Net Income, GAAP
48.41%
62.61%
-42.74%
Free Cash Flow
12.38%
3.59%
-25.45%
Total Cash Common Dividend
- -
- -
- -
Total Equity
-5.71%
-17.33%
-6.16%
Quarterly Dividends Per Share
USD

•

in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Working Capital
USD

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
Total Current Assets
3,155
3,040
3,002
Cash, Cash Equivalents & STI
322
367
340
Accounts Receivable, Net
2,132
2,058
2,010
Inventories
109
107
110
Total Current Liabilities
2,620
2,565
2,403
Payables & Accruals
498
513
460
ST Debt
627
637
496
Deferred Revenue
- -
- -
- -
Quarterly Revenue
USD

•

in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
2,820
2,917
2,938
2,944
11,619
2022
2,818
2,927
2,949
2,917
11,610
2023
2,873
3,000
- -
- -
- -
Quarterly Earnings Per Share
USD

•

in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
2.18
2.76
2.48
1.86
9.30
2022
1.68
2.38
1.16
0.76
6.03
2023
1.28
1.96
- -
- -
- -
Capital Structure
USD

•

in mil. unless spec.
Dec'22
Mar'23
Jun'23
ST Debt
627
637
496
LT Borrowings
8,693
8,418
8,598
LT Finance Leases
2,503
2,455
2,384
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
90
91
91
Market Capitalization
6,751
7,353
9,170